Atlantic (Aln Hlth) L. General Sells 6,246,096 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Key Points

• Alignment Healthcare Director sold 6,246,096 shares at an average price of $16.01, totaling nearly $100 million, which reduced their ownership stake by 20.25%.
• The company reported a 49% increase in revenue year-over-year, with earnings of $0.07 per share, exceeding analysts' expectations for the quarter.
• Institutional investors own 86.19% of Alignment Healthcare's stock, with notable increases in positions from major firms like Vanguard and T. Rowe Price during the first quarter.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) Director Atlantic (Aln Hlth) L. General sold 6,246,096 shares of the stock in a transaction dated Wednesday, September 17th. The stock was sold at an average price of $16.01, for a total transaction of $99,999,996.96. Following the completion of the sale, the director directly owned 24,596,079 shares in the company, valued at approximately $393,783,224.79. This trade represents a 20.25% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Alignment Healthcare Stock Performance

NASDAQ ALHC traded up $0.55 on Monday, hitting $17.09. The stock had a trading volume of 2,329,627 shares, compared to its average volume of 4,276,943. The company's 50-day moving average is $14.78 and its two-hundred day moving average is $15.59. Alignment Healthcare, Inc. has a one year low of $9.15 and a one year high of $21.06. The stock has a market cap of $3.38 billion, a price-to-earnings ratio of -61.03 and a beta of 1.17. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $960.25 million. During the same period in the previous year, the firm posted ($0.13) earnings per share. The business's revenue was up 49.0% on a year-over-year basis. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. Barclays raised shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and upped their price objective for the stock from $9.00 to $13.00 in a report on Thursday, July 31st. KeyCorp upgraded shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target on the stock in a research report on Monday, August 25th. Zacks Research upgraded shares of Alignment Healthcare to a "hold" rating in a report on Friday, August 8th. Wall Street Zen lowered shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. Finally, Stephens upgraded Alignment Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $18.83.

Institutional Trading of Alignment Healthcare

A number of large investors have recently added to or reduced their stakes in the business. BNP Paribas Financial Markets bought a new position in shares of Alignment Healthcare in the fourth quarter valued at $234,000. Deutsche Bank AG grew its holdings in shares of Alignment Healthcare by 48.3% in the 4th quarter. Deutsche Bank AG now owns 93,582 shares of the company's stock worth $1,053,000 after acquiring an additional 30,489 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Alignment Healthcare by 3.9% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 56,963 shares of the company's stock valued at $641,000 after purchasing an additional 2,154 shares during the last quarter. ProShare Advisors LLC boosted its position in shares of Alignment Healthcare by 49.0% in the 4th quarter. ProShare Advisors LLC now owns 28,188 shares of the company's stock valued at $317,000 after purchasing an additional 9,274 shares during the period. Finally, Two Sigma Advisers LP acquired a new position in shares of Alignment Healthcare in the 4th quarter valued at $436,000. 86.19% of the stock is currently owned by institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.